Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis
Authors:
- B E MageraBMB E Magera
- J C ArroyoJAJ C Arroyo
- S J RosanskySRS J Rosansky
- B PosticBPB Postic
Open Access
- 1 May 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 23 (5) , 710-714
Abstract
Vancomycin pharmacokinetics were studied in four patients with peritonitis undergoing chronic intermittent peritoneal dialysis. Serum levels exceeding 4.0 micrograms/ml were maintained for 8 and 13 days after a single 1-g intravenous dose. Vancomycin serum concentrations measured before, during, and upon completion of dialysis revealed no appreciable decline. Peritoneal fluid concentrations in two patients exceeded 4.0 micrograms/ml for more than 12 days.Keywords
This publication has 9 references indexed in Scilit:
- Single‐Dose Kinetics of Intravenous VancomycinThe Journal of Clinical Pharmacology, 1980
- Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrationsAntimicrobial Agents and Chemotherapy, 1980
- Clinical pharmacology and efficacy of vancomycin in pediatric patientsThe Journal of Pediatrics, 1980
- Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidisAntimicrobial Agents and Chemotherapy, 1979
- Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.1979
- Peritoneal Transport of Vancomycin during Peritoneal DialysisNephron, 1979
- Vancomycin RevisitedAnnals of Internal Medicine, 1978
- Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.1971
- Vancomycin for Staphylococcal Shunt Site Infections in Patients on Regular HaemodialysisBMJ, 1970